41
Participants
Start Date
January 24, 2020
Primary Completion Date
January 31, 2023
Study Completion Date
May 30, 2023
AdVEGFXC1
AdVEGFXC1 at one of 4 doses
Lehigh Valley Health Network, Allentown
MedStar Washington Hospital Center, Washington D.C.
Duke University, Durham
Emory University, Atlanta
Cardiology Research Associates, Daytona Beach
University of Florida, Gainesville
James A. Haley VA Medical Center, Tampa
The Ohio State University, Columbus
Cleveland Clinic, Cleveland
The Christ Hospital / The Lindner Research Center, Cincinnati
University of Cincinnati, Cincinnati
Minneapolis Heart Institute Foundation, Minneapolis
Houston Methodist, Houston
Texas Heart Institute, Houston
Stanford University, Stanford
University of Washington, Seattle
XyloCor Therapeutics, Inc.
INDUSTRY